European Child & Adolescent Psychiatry

, Volume 18, Issue 9, pp 583–585 | Cite as

Niemann–Pick disease type C1 presenting with psychosis in an adolescent male

  • Sabine Sandu
  • Sabine Jackowski-Dohrmann
  • Axel Ladner
  • Michael Haberhausen
  • Christian Bachmann
Case Report


Niemann–Pick disease, a neurovisceral lysosomal lipid storage disorder, is a rare disorder that is unknown to many clinicians. The disease, that often has its onset during childhood or adolescence, shows a polymorphic clinical picture, including psychiatric symptoms. Because of its infrequence, Niemann–Pick disease is diagnosed with an average delay of 6 years. This report presents a case of an adolescent male whose symptoms had led to various hospitalisations and psychiatric diagnoses. When he presented with psychotic symptoms in our department, thorough diagnosis revealed Niemann–Pick disease type C1 as the underlying disease.


Adolescence Niemann–Pick disease Organic psychosis Sphingomyelin lipidosis 


  1. 1.
    Campo JV, Stowe R, Slomka G, Byler D, Gracious B (1998) Psychosis as a presentation of physical disease in adolescence: a case of Niemann–Pick disease, type C. Dev Med Child Neurol 40:126–129PubMedCrossRefGoogle Scholar
  2. 2.
    Garver WS, Francis GA, Jelinek D, Shepherd G, Flynn J, Castro G, Walsh Vockley C, Coppock DL, Pettit KM, Heidenreich RA, Meaney FJ (2007) The national Niemann–Pick C1 disease database: report of clinical features and health problems. Am J Med Genet Part A 143:1204–1211Google Scholar
  3. 3.
    Imrie J, Vijayaraghaven S, Whitehouse C, Harris S, Heptinstall L, Church H, Cooper A, Besley GT, Wraith JE (2002) Niemann–Pick disease type C in adults. J Inherit Metab Dis 25:491–500PubMedCrossRefGoogle Scholar
  4. 4.
    Josephs KA, Van Gerpen MW, Van Gerpen JA (2003) Adult onset Niemann–Pick disease type C presenting with psychosis. J Neurol Neurosurg Psychiatry 74:528–529PubMedCrossRefGoogle Scholar
  5. 5.
    Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM (2009) Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1−/− mouse. Proceedings of the National Academy of Sciences of the United States of America Jan 26 (Epub ahead of print)Google Scholar
  6. 6.
    Niemann A (1914) Ein unbekanntes Krankheitsbild. Jahrbuch der Kinderheilkunde 1Google Scholar
  7. 7.
    Patterson MC, Vanier MT, Suzuki K, Morris JA, Carstea ED, Neufeld EB, Blanchette-Mackie EJ, Pentchev PG (2001) Niemann–Pick disease type C, a lipid trafficking disorder. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited diseases, 8th edn. McGraw-Hill, New York, pp 3611–3634Google Scholar
  8. 8.
    Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE (2007) Miglustat for treatment of Niemann–Pick C disease: a randomised controlled study. Lancet Neurol 6:765–772PubMedCrossRefGoogle Scholar
  9. 9.
    Pick L (1933) Niemann–Pick`s disease and other forms of so called xanthomatosis. Am J Med Sci 185:601–616Google Scholar
  10. 10.
    Sévin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F (2007) The adult form of Niemann–Pick disease type C. Brain 130:120–133PubMedCrossRefGoogle Scholar
  11. 11.
    Walterfang M, Fietz M, Fahey M, Sullivan D, Leane P, Lubman DI, Velakoulis D (2006) The Neuropsychiatry of Niemann–Pick Type C disease in adulthood. J Neuropsychiatry Clin Neurosci 18:158–170PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Sabine Sandu
    • 1
  • Sabine Jackowski-Dohrmann
    • 1
  • Axel Ladner
    • 1
  • Michael Haberhausen
    • 1
  • Christian Bachmann
    • 1
    • 2
  1. 1.University Hospital Giessen and MarburgMarburgGermany
  2. 2.Charité, Universitätsmedizin BerlinBerlinGermany

Personalised recommendations